Identification of SALL4 Expressing Islet-1+ Cardiovascular Progenitor Cell Clones
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24021780 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Andrea Monteon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Human Anatomy, Loma Linda University School of Medicine, Loma Linda, CA 92350, USA. Hauptthemen laut MEDLINE: Transcription Factors, Endothelial Cells. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: California Institute for Regenerative Medicine, California Institute for Regenerative Medicine (CIRM) Bridges to Stem Cell Research Program.
Abstract (Originalsprache)
The utilization of cardiac progenitor cells (CPCs) has been shown to induce favorable regenerative effects. While there are various populations of endogenous CPCs in the heart, there is no consensus regarding which population is ideal for cell-based regenerative therapy. Early-stage progenitor cells can be differentiated into all cardiovascular lineages, including cardiomyocytes and endothelial cells. Identifying an Islet-1+ (Isl-1+) early-stage progenitor population with enhanced stemness, multipotency and differentiation potential would be beneficial for the development of novel regenerative therapies. Here, we investigated the transcriptome of human neonatal Isl-1+ CPCs. Isl-1+ human neonatal CPCs exhibit enhanced stemness properties and were found to express Spalt-like transcription factor 4 (SALL4). SALL4 plays a role in embryonic development as well as proliferation and expansion of hematopoietic progenitor cells. SALL4, SOX2, EpCAM and TBX5 are co-expressed in the majority of Isl-1+ clones isolated from neonatal patients. The pre-mesendodermal transcript TFAP2C was identified in select Isl-1, SALL4, SOX2, EpCAM and TBX5 expressing clones. The ability to isolate and expand pre-mesendodermal stage cells from human patients is a novel finding that holds potential value for applications in regenerative medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Human Anatomy, Loma Linda University School of Medicine, Loma Linda, CA 92350, USA.
ORCID-Profile: Victor Camberos
Förderung
- California Institute for Regenerative Medicine
- California Institute for Regenerative Medicine (CIRM) Bridges to Stem Cell Research Program
Zitieren
APA
Monteon, A., Hughes, L., Camberos, V., & Kearns-Jonker, M. (2023). Identification of SALL4 Expressing Islet-1+ Cardiovascular Progenitor Cell Clones. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24021780
Vancouver
Monteon A, Hughes L, Camberos V, Kearns-Jonker M. Identification of SALL4 Expressing Islet-1+ Cardiovascular Progenitor Cell Clones. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24021780
BibTeX
@article{Monteon2023,
author = {Monteon, Andrea and Hughes, Lorelei and Camberos, Victor and Kearns-Jonker, Mary},
title = {Identification of SALL4 Expressing Islet-1+ Cardiovascular Progenitor Cell Clones},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24021780}
}
EUVIMED